Sort
39,280 grants matching “leukemia”
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$592,644Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2022 · CA
The role of innate immunity in downregulation of the airway antioxidant response during paramyxovirus infection
$592,500Antonella Casola · University Of Texas Med Br Galveston · P01 · FY2019 · AI
The function of MS4A3 in normal and malignant hematopoiesis
$592,404Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2024 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$592,164Shan Zha · Columbia University Health Sciences · R01 · FY2025 · CA
LY-1 B Cells: Developmental Origins and V Gene Biases
$592,133Richard R Hardy · Research Inst Of Fox Chase Can Ctr · R01 · FY2011 · AI
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$592,071Frederic D Bushman · University Of Pennsylvania · R01 · FY2023 · CA
Clonal hematopoiesis, mild cognitive impairment and kidney function decline
$592,058Michel Benjamin Chonchol · University Of Colorado Denver · R01 · FY2024 · AG
Small-molecule degraders of BET proteins
$592,054Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Proteasome/HDAC Inhibition in Leukemia/MDS; Phase I Trial and Correlative Studies
$591,990Steven Grant · Virginia Commonwealth University · RC2 · FY2009 · CA
Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy
$591,928Daniel Fowler · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Project 1: Effects of inflammation on clonal competition and malignant transformation
$591,928Katherine Yudeh King · Baylor College Of Medicine · P01 · FY2024 · CA
NCTN Lead Academic Participating Sites Application
$591,897Lisa A Carey · Univ Of North Carolina Chapel Hill · U10 · FY2015 · CA
Protein Structure, Stability, and Amyloid Formation
$591,716Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$591,527Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
GENETICS AND MECHANISMS OF DLI EFFECTS FOLLOWING NON-MYELOBLATIVE HCT
$591,425David H Sachs · Massachusetts General Hospital · P01 · FY2007 · CA
Role of Phase separation by fusion oncoproteins in oncogenesis
$591,406Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Down syndrome: Bridging Genes, Brain and Cognition
$591,397Julie R Korenberg · University Of Utah · R01 · FY2011 · HD
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
$591,372Areej El-Jawahri · Massachusetts General Hospital · R01 · FY2024 · CA
Stem Cells, Differentiation and Therapeutic Resistance in AML
$591,204Martin Carroll · University Of Pennsylvania · R01 · FY2015 · CA
Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency
$591,158Dennis Hickstein · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
$591,132Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Clinical Trials Office
$591,101James P Thomas · Ohio State University · P30 · FY2014 · CA
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell
$591,097Shujun Liu · Case Western Reserve University · R01 · FY2023 · CA
Inflammation, Macrophage Differentiation, and Cancer
$591,089Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy
$590,960Russell Christian Rockne · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA